IFNA2 and chronic hepatitis C virus infection: It has been reported, however, that some 8% of patients with chronic hepatitis C infection who failed to respond to therapy with pegylated IFNα2 and ribavirin, had circulating neutralizing anti-IFNα antibodies while none of the patients who cleared HCV following IFN therapy had detectable levels of anti-IFNαNAbs [152].